Article
Baltimore-Treatment of people with ocular hypertension without a diagnosis of glau-coma has been poorly understood, but there is no doubt that the Ocular Hypertension Treatment Study (OHTS) has brought the field a lot farther.
Beyond mentoring: The power of sponsorship and advocacy in ophthalmology
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Character Biosciences secures $93 million series B financing round
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Alcon agrees to purchase LENSAR
Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint